Veranova: A CDMO that manages complexity with confidence.
01 1MACFARLAN SMITH LIMITED Edinburgh GB
02 1ALKALOIDA CHEMICAL COMPANY ZRT. Tiszavasvari HU
03 1S.A.L.A.R.S. S.p.A. Como IT
04 1SANECA PHARMACEUTICALS A.S. Hlohovec SK
Veranova: A CDMO that manages complexity with confidence.
Dihydrocodeine Hydrogen Tartrate
Certificate Number : R1-CEP 2003-209 - Rev 01
Status : Valid
Issue Date : 2015-02-13
Type : Chemical
Substance Number : 1776
86
PharmaCompass offers a list of Dihydrocodeine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydrocodeine Tartrate manufacturer or Dihydrocodeine Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydrocodeine Tartrate manufacturer or Dihydrocodeine Tartrate supplier.
PharmaCompass also assists you with knowing the Dihydrocodeine Tartrate API Price utilized in the formulation of products. Dihydrocodeine Tartrate API Price is not always fixed or binding as the Dihydrocodeine Tartrate Price is obtained through a variety of data sources. The Dihydrocodeine Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer, including repackagers and relabelers. The FDA regulates dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer supplier is an individual or a company that provides dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer active pharmaceutical ingredient (API) or dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer finished formulations upon request. The dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer suppliers may include dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer API manufacturers, exporters, distributors and traders.
click here to find a list of dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP of the European Pharmacopoeia monograph is often referred to as a dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer Certificate of Suitability (COS). The purpose of a dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer to their clients by showing that a dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP has been issued for it. The manufacturer submits a dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP (COS) as part of the market authorization procedure, and it takes on the role of a dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP holder for the record. Additionally, the data presented in the dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer DMF.
A dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer suppliers with CEP (COS) on PharmaCompass.
We have 4 companies offering dihydrocodeine tartrate (1:1), (5alpha,6beta)-(R-(R*,R*))-isomer
Get in contact with the supplier of your choice:
